One-Year Outcomes Following Intravenous Ketamine Plus Digital Training Among Patients with Treatment-Resistant Depression
R. Price, M. Wallace, S. Mathew, Robert H Howland
JAMA Network Open May 1, 2023 DOI: 10.1001/jamanetworkopen.2023.12434 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Secondary analysis of a randomized clinical trial Peer reviewed |
|---|---|
| Population | Patients with treatment-resistant depression |
| Intervention | automated self-association training |
| Topics | Depression Esketamine Ketamine |
| Citations | 9 |
| Key findings | Automated self-association training may prolong the antidepressant effect of a single ketamine infusion beyond one month in patients with treatment-resistant depression. |
Abstract
This secondary analysis of a randomized clinical trial examines whether automated self-association training can prolong the antidepressant effect of a single infusion of ketamine beyond 1 month in patients with treatment-resistant depression.